Lanreotide Autogel in the Treatment of Idiopathic Refractory Diarrhea: Results of an Exploratory, Controlled, Before and After, Open-label, Multicenter, Prospective Clinical Trial-Reference-Cited by-同舟云学术

Lanreotide Autogel in the Treatment of Idiopathic Refractory Diarrhea: Results of an Exploratory, Controlled, Before and After, Open-label, Multicenter, Prospective Clinical Trial

Published:2016-08 Issue:8 Volume:38 Page:1902-1911.e2
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Bisschops Raf,De Ruyter Vincent,Demolin Gauthier,Baert Didier,Moreels Tom,Pattyn Piet,Verhelst Hans,Lepoutre Luc,Arts Joris,Caenepeel Philip,Ooghe Patrick,Codden Thierry,Maisonobe Pascal,Petrens Elke,Tack Jan

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference32 articles.

1. Guidelines for the Investigation of Chronic Diarrhoea, 2nd edition;Thomas;Gut,2003

2. AGA technical review on the evaluation and management of chronic diarrhea;Fine;Gastroenterology,1999

3. Evaluation of chronic diarrhea;Juckett;Am Fam Physician,2011

4. Lanreotide Autogel Autogel®: a review of its use in the treatment of patients with acromegaly;Burness;Drugs,2014

5. SMS 201-885 a somatostatin analogue and diarrhea in AIDS;Holmberg;Ann Intern Med,1988

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Managing gastrointestinal manifestations in systemic sclerosis, a mechanistic approach;Expert Review of Clinical Immunology;2024-02-26

2. Current and Future Therapeutic Options for Irritable Bowel Syndrome with Diarrhea and Functional Diarrhea;Digestive Diseases and Sciences;2022-11-14

3. Gastrointestinal hormones and regulation of gastric emptying;Current Opinion in Endocrinology, Diabetes & Obesity;2022-01-25

4. Drugs in Focus: Octreotide Use in Children With Gastrointestinal Disorders;Journal of Pediatric Gastroenterology & Nutrition;2021-09-09

5. Lanreotide in the prevention and management of high-output ileostomy after colorectal cancer surgery;Journal of Drug Assessment;2018-01